A61K 35/48
Reproductive organs
A61K35/48 (Reproductive organs) appears on 1,703 US grants and 3,562 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,703
- Published applications
- 3,562
- Assignees
- 1,271
- Inventors
- 5,027
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 4 | 0 |
| 1978 | 7 | 0 |
| 1979 | 3 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 6 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 4 | 0 |
| 1987 | 4 | 0 |
| 1988 | 5 | 0 |
| 1989 | 3 | 0 |
| 1990 | 5 | 0 |
| 1991 | 6 | 0 |
| 1992 | 6 | 0 |
| 1993 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 6 | 0 |
| 1996 | 6 | 0 |
| 1997 | 14 | 0 |
| 1998 | 18 | 0 |
| 1999 | 8 | 0 |
| 2000 | 6 | 0 |
| 2001 | 10 | 3 |
| 2002 | 5 | 22 |
| 2003 | 13 | 21 |
| 2004 | 1 | 38 |
| 2005 | 6 | 45 |
| 2006 | 5 | 48 |
| 2007 | 10 | 70 |
| 2008 | 13 | 66 |
| 2009 | 19 | 73 |
| 2010 | 21 | 84 |
| 2011 | 24 | 96 |
| 2012 | 44 | 131 |
| 2013 | 65 | 156 |
| 2014 | 91 | 173 |
| 2015 | 94 | 199 |
| 2016 | 89 | 244 |
| 2017 | 114 | 194 |
| 2018 | 100 | 210 |
| 2019 | 134 | 224 |
| 2020 | 98 | 243 |
| 2021 | 116 | 239 |
| 2022 | 106 | 242 |
| 2023 | 96 | 236 |
| 2024 | 108 | 202 |
| 2025 | 116 | 169 |
| 2026 | 70 | 134 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods for providing hematopoietic function without HLA matching22 Sep 2026US 12,741,001 B2Fred Hutchinson Cancer Center
- Composition for treating infectious diseases, comprising exosomes derived from thrombin-treated stem cells15 Sep 2026US 12,734,195 B2Samsung Life Public Welfare Foundation
- Equine-specific therapeutic compositions and methods of use8 Sep 2026US 12,728,141 B2Equistem Technology, LLC
- Extracellular vesicles from stem cells to treat and/or prevent disease1 Sep 2026US 12,721,867 B2Children’s Hospital Los Angeles
- Treatment of radicular pain with cell-free amniotic fluid1 Sep 2026US 12,721,868 B2University of Utah Research Foundation
- Intranasal delivery of cd34+ cells for the treatment of stroke8 Oct 2026US 2026/0306537 A1Cellprothera
- Endothelial cells for treatment of gastrointestinal fistula8 Oct 2026US 2026/0306551 A1Angiocrine Bioscience, Inc.
- Methods of preventing on-target genotoxicity induced by nucleases8 Oct 2026US 2026/0306552 A1Chu De Bordeaux
- Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof1 Oct 2026US 2026/0294976 A1Amniotics AB
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
Most cited
By later US patents
- Repair of cartilage and bones372US 4,642,120 ARamot University Authority for Applied Research and Industrial Development Ltd. · 1987
- Methods of making conditioned cell culture medium compositions249US 6,372,494 B1Advanced Tissue Sciences, Inc. · 2002
- Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use242US 5,192,553 ABiocyte Corporation · 1993
- Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood229US 5,004,681 ABiocyte Corporation · 1991
- Reconstituted basement membrane complex with biological activity212US 4,829,000 AThe United States of America, as represented by the Secretary, Department of Health and Human Services · 1989